Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct 22;17(21):7732.
doi: 10.3390/ijerph17217732.

State of Fragility Fractures Management during the COVID-19 Pandemic

Umberto Tarantino  1   2 , Ida Cariati  1   3 , Virginia Tancredi  4   5 , Donato Casamassima  2 , Eleonora Piccirilli  2 , Riccardo Iundusi  2 , Elena Gasbarra  2
Affiliations
Review

State of Fragility Fractures Management during the COVID-19 Pandemic

Umberto Tarantino et al. Int J Environ Res Public Health. .

Abstract

Osteoporosis is a public health concern all over the world. As a chronic condition, it generally requires prolonged medical interventions to limit the risks of further bone loss, impaired skeletal integrity and the onset of fractures. This problem is further complicated by the fact that the abrupt cessation of some therapies may be associated with an increased risk of harm. It is in this context that the COVID-19 pandemic has caused an unprecedented disruption to the provision of healthcare worldwide, exceeding our worst expectations in terms of the number of lives lost and the rapidity at which consolidated economies and healthcare systems are being significantly damaged. In this review, we assessed the challenges and strategies used in the management of osteoporosis and fragility fracture care during the COVID-19 pandemic. We also examined the available evidence and provided clinical recommendations that will require reassessment as the worldwide response to COVID-19 evolves.

Keywords: COVID-19; aging; fragility fractures; healthcare; osteoporosis; pandemic; pulmonary infection.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Modifiable factors concerning daily lifestyle.
See this image and copyright information in PMC

References

    1. Guan W.J., Ni Z.Y., Hu Y., Liang W.H., Ou C.Q., He J.X., Liu L., Shan H., Lei C.L., Hui D.S.C., et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020;382:1708–1720. doi: 10.1056/NEJMoa2002032. - DOI - PMC - PubMed
    1. Chen N., Zhou M., Dong X., Qu J., Gong F., Han Y., Qiu Y., Wang J., Liu Y., Wei Y., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study. Lancet. 2020;395:507–513. doi: 10.1016/S0140-6736(20)30211-7. - DOI - PMC - PubMed
    1. Liguori C., Mercuri N.B., Izzi F., Romigi A., Cordella A., Piccirilli E., Viola S., Costa S., Sbraccia P., Marciani M.G., et al. Obstructive Sleep Apnoea as a Risk Factor for Osteopenia and Osteoporosis in the Male Population. Eur. Respir. J. 2016;47:987–990. doi: 10.1183/13993003.01830-2015. - DOI - PubMed
    1. Tarantino U., Piccirilli E., Fantini M., Baldi J., Gasbarra E., Bei R. Sarcopenia and Fragility Fractures: Molecular and Clinical Evidence of the Bone-Muscle Interaction. J. Bone Joint Surg. Am. 2015;97:429–437. doi: 10.2106/JBJS.N.00648. - DOI - PubMed
    1. Yu E.W., Tsourdi E., Clarke B.L., Bauer D.C., Drake M.T. Osteoporosis Management in the Era of COVID-19. J. Bone Miner. Res. 2020;35:1009–1013. doi: 10.1002/jbmr.4049. - DOI - PMC - PubMed